Research Guides

 
Stock Quotes for Research Guides top ^
  • Industry: Medical Devices
  • Sector: Healthcare
  • Stock Style: Small Core
  • Stock Type: Distressed
Sign-up for gthp investment picks
  • Industry: Medical Devices
  • Sector: Healthcare
  • Stock Style: Small Core
  • Stock Type: Distressed
Sign-up for gthp investment picks
  • Industry: Medical Instruments & Supplies
  • Sector: Healthcare
  • Stock Style: Mid Growth
Sign-up for 002414 investment picks
  • Industry: Software - Application
  • Sector: Technology
  • Stock Style: Small Growth
  • Stock Type: Distressed
Sign-up for guid investment picks
  • Industry: Software - Application
  • Sector: Technology
  • Stock Style: Small Growth
  • Stock Type: Distressed
Sign-up for guid investment picks

 
News Articles for Research Guides top ^
2014/9/22
Company to mark occasion with private gala that will honor the city's starred chefs and New York's rich and diverse food scene NEW YORK , Sept.
Sign-up for Michelin To Celebrate 10th Edition Of The New York City MICHELIN Guide investment picks
Rovi Corporation (NASDAQ:ROVI) today unveiled its new HTML5-based, multiplatform Rovi Guide, designed to allow service providers and device manufacturers around the globe to rapidly create and deploy next-generation entertainment discovery and monetization solutions across multiple screens.
Sign-up for Rovi Introduces Cloud-Based Multiscreen Entertainment Guide investment picks
Guided Therapeutics, Inc. (OTCBB: GTHP) (OTCQB: GTHP) today announced that it will begin enrollment this week in a multi-center clinical trial to expand claims for the LuViva® Advanced Cervical Scan to include front-line screening for cervical cancer.
Sign-up for Guided Therapeutics Initiates Cervical Cancer Screening Trial for LuViva® Advanced Cervical Scan investment picks
Guided Therapeutics, Inc. (OTCBB: GTHP) (OTCQB: GTHP) today announced that its Turkish distributor, ITEM Medical Technologies Group, referred to as ITEM, has committed to invest $200,000 in a private placement of Guided Therapeutics’ common stock.
Sign-up for Guided Therapeutics Announces Initial $200,000 Investment from Turkish Distributor, ITEM Medical Technologies Group investment picks
Guided Therapeutics, Inc. (OTCBB: GTHP) (OTCQB: GTHP) today announced that it has filed an amendment to its premarket approval (PMA) application with the U.S. Food and Drug Administration (FDA) for the LuViva ® Advanced Cervical Scan.
Sign-up for Guided Therapeutics Files PMA Amendment with FDA for LuViva® Advanced Cervical Scan investment picks
Guided Therapeutics, Inc. (OTCBB: GTHP) (OTCQB: GTHP) today announced that U.S. Patent and Trademark Office granted a new patent with 22 claims that support the technology behind the LuViva ® Advanced Cervical Scan.
Sign-up for Guided Therapeutics Granted Additional Key Patent for LuViva® Advanced Cervical Scan investment picks
Guided Therapeutics, Inc. (OTCBB: GTHP) (OTCQB: GTHP) today announced its operating results for the second quarter and six months ended June 30, 2014.
Sign-up for Guided Therapeutics Reports Second Quarter 2014 Results investment picks
St. Jude Medical, Inc. (NYSE: STJ), a global medical device company, today announced primary outcome two-year data from the FAME 2 Trial which demonstrated sustained superiority with FFR-guided PCI using St.
Sign-up for Two Year Data from FAME 2 Trial Shows Sustained Benefits of FFR-Guided PCI over Medical Treatment in Patients with Stable CAD investment picks
Rand Worldwide (OTCBB: RWWI), a global leader in providing technology solutions to organizations with engineering design and information technology requirements, today announced that its courseware division, ASCENT – Center for Technical Knowledge , has surpassed the milestone of 30 released Autodesk Official Training Guides (AOTG) in the past four months for Autodesk’s 2015 software.
Sign-up for ASCENT - Center for Technical Knowledge Adds Additional Autodesk Official Training Guide Titles to its Current 2015 Offering investment picks
Rovi Corporation (NASDAQ:ROVI) today announced the successful deployment of its guides on over half a million standard and high-definition digital terminal adapters (DTAs). As a result of commercial agreements with more than a dozen leading cable operators including Armstrong, and Cablevision Argentina, as well as successful collaborations with leading equipment manufacturers such as Arris, Evolution Digital and Pace, Rovi is now providing its multi-featured TV programming guide to cable households throughout the U.S. and Latin America.
Sign-up for Rovi Hits a Major Milestone With the Deployment of Over Half a Million DTA Guides investment picks
2014/9/5
Intel's 2014 Back to School Buying Guide is available on Business Wire's website.
Sign-up for Intel's 2014 Back to School Buying Guide Available on Business Wire's Website investment picks
Guided Therapeutics, Inc. (OTCBB: GTHP) (OTCQB: GTHP) developer of the LuViva ® Advanced Cervical Scan, a non-invasive device used to detect cervical disease that leads to cancer, today announced that it will be a featured presenter at the Rodman & Renshaw 16 th Annual Global Investment Conference on Wednesday, September 10, 2014 at the New York Palace Hotel in New York City.
Sign-up for Guided Therapeutics to Present at Rodman & Renshaw 16th Annual Global Investment Conference on Wednesday, September 10th investment picks
Guided Therapeutics, Inc. (OTCBB: GTHP) (OTCQB: GTHP), developer of a rapid and painless testing platform that uses biophotonics for the early detection of disease, today announced that it is scheduled to report financial results for its second quarter ended June 30, 2014 on Wednesday, August 13, 2014, after the market closes.
Sign-up for Guided Therapeutics to Report Second Quarter 2014 Results and Hold Conference Call investment picks
Pioneer in uniting imaging technology with radiotherapy to explore potential of MRI to refine tumor targeting MANCHESTER, England , July 22, 2014 /PRNewswire/ -- Elekta (NSE:EKTAb) and Royal Philips (NYSE:PHG, AEX:PHIA) announced today that The Christie NHS Foundation Trust ( Manchester, UK ), a specialist cancer center, will join a consortium whose mission is to develop the clinical value of an integrated magnetic resonance imaging (MRI) guided radiation therapy system.
Sign-up for The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment investment picks
HughesON Suite of Managed Network Services Wins Bronze in IT Industry's Coveted "2014 Hot Companies and Best Products Awards" GERMANTOWN, Md.
Sign-up for Hughes Wins Best New Product Honors from Network Products Guide investment picks

Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Research Guides
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Research Groups  |  Next: Research Highlights